Description

This issue of Vital Signs, released on February 4, 2008, provides an strategic overview of the integration of genomics technology in proteomics analysis. Additionally, a company spotlight is provided for MSM Protein Technologies, an emerging biotechnology company with a suite of tools for drug discovery of functional antibodies and proteins against multi-spanning membrane proteins. Reimbursement and regulatory news from the FDA is also provided for the week of January 21 - January 25, 2008.